Haneen Daralnakhla1, Osama Saher1,2, Susanna Zamolo3, Safa Bazaz1,4, Jeremy P Bost1, Marc Heitz3, Karin E Lundin1, Samir El Andaloussi1, Tamis Darbre3, Jean-Louis Reymond3, Rula Zain1,5, C I Edvard Smith1. 1. Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 141 86 Huddinge, Sweden. 2. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt. 3. Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland. 4. Department of Biology, Faculty of Science, Cihan University-Erbil, Erbil 44001, Iraq. 5. Centre for Rare Diseases, Department of Clinical Genetics, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Abstract
Non-viral transfection reagents are continuously being developed in attempt to replace viral vectors. Among those non-viral vectors, dendrimers have gained increasing interest due to their unique molecular structure and multivalency. However, more improvements are still needed to achieve higher efficacy and lower toxicity. In this study, we have examined 18 peptide dendrimers conjugated to lipophilic moieties, such as fatty acids or hydrophobic amino acids, that were previously explored for siRNA. Reporter cells were employed to investigate the transfection of single strand splice-switching oligonucleotides (ONs) using these peptide dendrimers. Luciferase level changes reflecting efficiency varied with amino acid composition, stereochemistry, and complexation media used. 3rd generation peptide dendrimers with D-amino acid configuration were superior to L-form. Lead formulations with 3rd generation, D-amino acid peptide dendrimers increased the correction level of the delivered ON up to 93-fold over untreated HeLa Luc/705 cells with minimal toxicity. To stabilize the formed complexes, Polyvinyl alcohol 18 (PVA18) polymer was added. Although PVA18 addition increased activity, toxicity when using our best candidates G 2,3KL-(Leu)4 (D) and G 2,3KL-diPalmitamide (D) was observed. Our findings demonstrate the potential of lipid-conjugated, D-amino acid-containing peptide dendrimers to be utilized as an effective and safe delivery vector for splice-switching ONs.
Non-viral transfection reagents are continuously being developen>an class="Chemical">d in attempt to replace viral vectors. Among those non-viral vectors, dendrimers have gained increasing interest due to their unique molecular structure and multivalency. However, more improvements are still needed to achieve higher efficacy and lower toxicity. In this study, we have examined 18 peptide dendrimers conjugated to lipophilic moieties, such as fatty acids or hydrophobic amino acids, that were previously explored for siRNA. Reporter cells were employed to investigate the transfection of single strand splice-switching oligonucleotides (ONs) using these peptide dendrimers. Luciferase level changes reflecting efficiency varied with amino acid composition, stereochemistry, and complexation media used. 3rd generation peptide dendrimers with D-amino acid configuration were superior to L-form. Lead formulations with 3rd generation, D-amino acidpeptide dendrimers increased the correction level of the delivered ON up to 93-fold over untreatedHeLa Luc/705 cells with minimal toxicity. To stabilize the formed complexes, Polyvinyl alcohol 18 (PVA18) polymer was added. Although PVA18 addition increased activity, toxicity when using our best candidates G 2,3KL-(Leu)4 (D) and G 2,3KL-diPalmitamide (D) was observed. Our findings demonstrate the potential of lipid-conjugated, D-amino acid-containing peptide dendrimers to be utilized as an effective and safe delivery vector for splice-switching ONs.
Authors: Abirami Lakshminarayanan; Vijay Kumar Ravi; Ranjitha Tatineni; Y B R D Rajesh; Vishal Maingi; K S Vasu; Nandhitha Madhusudhan; Prabal K Maiti; A K Sood; Saumitra Das; N Jayaraman Journal: Bioconjug Chem Date: 2013-08-22 Impact factor: 4.774
Authors: Cristina S J Rocha; Karin E Lundin; Mark A Behlke; Rula Zain; Samir El Andaloussi; C I Edvard Smith Journal: Nucleic Acid Ther Date: 2016-09-15 Impact factor: 5.486
Authors: Małgorzata Wiśniewska; Iwona Ostolska; Katarzyna Szewczuk-Karpisz; Stanisław Chibowski; Konrad Terpiłowski; Vladimir Moiseevich Gun'ko; Vladimir Iljich Zarko Journal: J Nanopart Res Date: 2015-01-11 Impact factor: 2.253
Authors: Adriana Aurelia Chis; Carmen Dobrea; Claudiu Morgovan; Anca Maria Arseniu; Luca Liviu Rus; Anca Butuca; Anca Maria Juncan; Maria Totan; Andreea Loredana Vonica-Tincu; Gabriela Cormos; Andrei Catalin Muntean; Maria Lucia Muresan; Felicia Gabriela Gligor; Adina Frum Journal: Molecules Date: 2020-09-01 Impact factor: 4.411